45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 45,205 shares of the company’s stock, valued at approximately $1,062,000. Principal Financial Group Inc. owned approximately 0.08% of Stoke Therapeutics as of its most recent filing with the Securities and Exchange Commission (SEC). Get Stoke Therapeutics alerts: ...